| 1 |
-
Navigating liver transplantation after malabsorptive bariatric surgery – A new risk of rejection
-
5/29/2026 8:41:42 AM | Browse: 21 | Download: 91
|
| 2 |
-
Effect of cholecystectomy on liver fat and fibrosis in metabolic dysfunction-associated steatotic liver disease patients
-
5/27/2026 8:10:54 AM | Browse: 2 | Download: 16
|
| 3 |
-
Mediating roles of insulin resistance and inflammatory markers between healthy sleep scores and metabolic dysfunction-associated steatotic liver disease
-
5/26/2026 5:34:19 AM | Browse: 13 | Download: 35
|
| 4 |
-
Rethinking noninvasive steatosis indices: Structural limitations and misclassification across the body mass index spectrum
-
5/26/2026 3:52:12 AM | Browse: 4 | Download: 23
|
| 5 |
-
Kaempferol attenuates diet-induced obesity and hepatic steatosis in C57BL/6J mice fed an Indian diet-mimicking regimen
-
5/26/2026 3:52:09 AM | Browse: 4 | Download: 42
|
| 6 |
-
Association between overt, subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging
-
5/26/2026 3:52:08 AM | Browse: 4 | Download: 33
|
| 7 |
-
High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis
-
4/21/2026 8:57:44 AM | Browse: 27 | Download: 105
|
| 8 |
-
Modulation of the gut-liver axis by oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease
-
4/17/2026 7:16:57 AM | Browse: 82 | Download: 346
|
| 9 |
-
Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials
-
4/3/2026 6:41:52 AM | Browse: 34 | Download: 186
|
| 10 |
-
Exercise-responsive skeletal muscle genes mechanistically linked to metabolic dysfunction-associated steatotic liver disease
-
3/27/2026 6:07:06 AM | Browse: 67 | Download: 182
|
| 11 |
-
Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease
-
3/27/2026 6:07:05 AM | Browse: 38 | Download: 113
|
| 12 |
-
Role of hepatic sonic hedgehog protein expression in the diagnosis of metabolic dysfunction-associated steatohepatitis
-
3/19/2026 7:07:30 AM | Browse: 37 | Download: 219
|
| 13 |
-
Zhejiang University index - connecting type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: Clinical utility and future horizons
-
3/12/2026 9:18:15 AM | Browse: 40 | Download: 200
|
| 14 |
-
Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes
-
3/6/2026 8:56:27 AM | Browse: 97 | Download: 357
|
| 15 |
-
Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease via peroxisome proliferator-activated receptor alpha pathway activation
-
2/27/2026 8:35:11 AM | Browse: 33 | Download: 294
|
| 16 |
-
Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis
-
2/12/2026 11:20:21 AM | Browse: 84 | Download: 397
|
| 17 |
-
Liver clock: Malalignment and entrainment therapeutics
-
2/11/2026 3:41:43 AM | Browse: 65 | Download: 176
|
| 18 |
-
Fatty pancreas: Current insights and future perspectives
-
2/10/2026 10:35:39 AM | Browse: 65 | Download: 197
|
| 19 |
-
Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies
-
2/6/2026 8:43:37 AM | Browse: 88 | Download: 242
|
| 20 |
-
High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health
-
2/2/2026 7:26:02 AM | Browse: 77 | Download: 256
|
| 21 |
-
Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease
-
1/27/2026 10:12:32 AM | Browse: 140 | Download: 320
|
| 22 |
-
Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers
-
1/27/2026 10:12:31 AM | Browse: 96 | Download: 276
|
| 23 |
-
Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study
-
1/27/2026 10:12:31 AM | Browse: 66 | Download: 253
|
| 24 |
-
Not always autoimmune hepatitis: Hepatic steatosis is associated with autoantibodies positivity in patients with hepatocellular dysfunction
-
1/27/2026 10:12:31 AM | Browse: 132 | Download: 267
|
| 25 |
-
Metabolic-dysfunction associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review
-
1/15/2026 8:12:50 AM | Browse: 62 | Download: 161
|
| 26 |
-
Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches
-
1/12/2026 9:50:50 AM | Browse: 60 | Download: 172
|
| 27 |
-
Serum uric acid-to-high-density lipoprotein cholesterol ratio and cardiovascular risk in Asian patients with metabolic dysfunction-associated steatotic liver disease
-
12/27/2025 2:50:52 AM | Browse: 76 | Download: 336
|
| 28 |
-
Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption?
-
12/26/2025 10:27:35 AM | Browse: 97 | Download: 235
|
| 29 |
-
Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients
-
12/26/2025 10:27:34 AM | Browse: 151 | Download: 482
|
| 30 |
-
Integrated serum metabolomics reveal molecular mechanism of Xietu Hemu prescription on metabolic dysfunction-associated steatotic liver disease-related obesity
-
12/26/2025 10:27:31 AM | Browse: 103 | Download: 468
|
| 31 |
-
Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health
-
12/26/2025 10:27:30 AM | Browse: 120 | Download: 344
|
| 32 |
-
Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease
-
12/22/2025 7:43:01 AM | Browse: 100 | Download: 283
|
| 33 |
-
Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease
-
12/19/2025 10:39:41 AM | Browse: 96 | Download: 382
|
| 34 |
-
Artificial intelligence applications for managing metabolic dysfunction-associated steatotic liver disease: Current status and future prospects
-
12/19/2025 10:39:40 AM | Browse: 89 | Download: 337
|
| 35 |
-
Role of sodium-glucose co-transporter 2 inhibitors in liver diseases
-
12/19/2025 8:32:37 AM | Browse: 87 | Download: 297
|
| 36 |
-
Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients
-
12/15/2025 9:46:09 AM | Browse: 118 | Download: 284
|
| 37 |
-
Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis
-
12/10/2025 7:48:07 AM | Browse: 264 | Download: 467
|
| 38 |
-
Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends
-
12/5/2025 11:28:02 AM | Browse: 134 | Download: 320
|
| 39 |
-
Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges
-
12/3/2025 9:10:07 AM | Browse: 144 | Download: 356
|
| 40 |
-
Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes
-
11/27/2025 7:54:00 AM | Browse: 107 | Download: 326
|
| 41 |
-
Impact of alcohol-associated and metabolic dysfunction-associated steatotic liver diseases upon hepatic disorder and carcinogenesis in the current era
-
11/27/2025 7:53:59 AM | Browse: 94 | Download: 314
|
| 42 |
-
Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology
-
11/27/2025 7:53:58 AM | Browse: 82 | Download: 293
|
| 43 |
-
Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis
-
11/27/2025 7:53:58 AM | Browse: 120 | Download: 375
|
| 44 |
-
Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Machine learning for non-invasive diagnosis and risk stratification
-
11/27/2025 7:53:57 AM | Browse: 80 | Download: 246
|
| 45 |
-
Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
-
11/27/2025 7:53:54 AM | Browse: 82 | Download: 279
|
| 46 |
-
Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action
-
11/27/2025 7:53:52 AM | Browse: 83 | Download: 252
|
| 47 |
-
Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease
-
11/26/2025 3:57:03 AM | Browse: 95 | Download: 303
|
| 48 |
-
Clinical significance and pathogenic mechanisms of fatigue in metabolic dysfunction-associated steatotic liver disease
-
10/27/2025 10:57:53 AM | Browse: 215 | Download: 413
|
| 49 |
-
Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: Mechanisms and implications
-
10/27/2025 10:57:50 AM | Browse: 265 | Download: 292
|
| 50 |
-
Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice
-
10/27/2025 10:57:49 AM | Browse: 228 | Download: 438
|
